The Role of TP53 in Acute Myeloid Leukemia: Challenges and Opportunities

Genes Chromosomes and Cancer - United States
doi 10.1002/gcc.22796
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

New Drugs Creating New Challenges in Acute Myeloid Leukemia

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2019English

Challenges in Treating Older Patients With Acute Myeloid Leukemia

Journal of Oncology
Oncology
2010English

Identification of Key Pathways and Genes in TP53 Mutation Acute Myeloid Leukemia: Evidence From Bioinformatics Analysis

OncoTargets and Therapy
OncologyPharmacology
2017English

Retraction Note: Frequency of TP53 Mutations and Its Impact on Drug Sensitivity in Acute Myeloid Leukemia?

Indian Journal of Clinical Biochemistry
Clinical Biochemistry
2014English

Acute Myeloid Leukemia

JAMA - Journal of the American Medical Association
Medicine
2010English

Off-Target Based Drug Repurposing Opportunities for Tivantinib in Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2019English

Acute Myeloid Leukemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Role of MRP1 in Multidrug Resistance in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

The Evolving Role of FLT3 Inhibitors in Acute Myeloid Leukemia: Quizartinib and Beyond

Therapeutic Advances in Hematology
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy